Therapy of neoplasms of the maxilla

Therapy of neoplasms of the maxilla - NeMa

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004515

Enrollment

119

Registered

2012-12-06

Start date

2012-10-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C05 C06 C03

Interventions

Group 1: Patients with different malignant tumors of the midface are compared within the treatment, the quality of life and the survival rate are calculated.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Therapy between the years 1995 until 2010 in ZMK Freiburg, diagnosis and primary therapy: neoplasms of the maxilla or palate, base of the skull or nose sinuses

Exclusion criteria

Exclusion criteria: - Tumors with malignant skin structure - benign tumor - second-therapy - malignant tumors of the tongue, floor of mouth, mandible

Design outcomes

Primary

Measure	Time frame
The data from the medical records are acquired one-time retrospective with a registration sheet on 30.10.2012.The data related to age, sex, therapy, posttreatment symptoms and survival of these patients.	—

Countries

Germany

Contacts

Public ContactUlrike Markmann

Uniklinikum Freiburg

Ulrike-Markmann@gmx.de017663137550

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026